Atomoxetine Hydrochloride
- Product NDC
- 50268-059
- 11-digit product format
- 502680059
- Labeler code
- 50268
- Product ID
- 50268-059_4587bd5f-1bd2-c809-e063-6294a90adf87
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atomoxetine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA078983
- Marketing category
- ANDA
- Marketing start
- 2020-07-07
- Substance
- ATOMOXETINE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078983-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A078983-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A078983-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A078983-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A078983-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A078983-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A078983-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078983-001 | AB |
| A078983-002 | AB |
| A078983-003 | AB |
| A078983-004 | AB |
| A078983-005 | AB |
| A078983-006 | AB |
| A078983-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078983-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078983-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078983-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078983-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078983-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078983-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078983-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078983-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078983-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078983-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078983-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078983-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078983-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078983-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atomoxetine Hydrochloride | ATOMOXETINE HYDROCHLORIDE | AvPAK | 9e787cc2-5d0f-f231-e053-2a95a90ae99a | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 078983 ANDA078983 |
| Atomoxetine Hydrochloride | ATOMOXETINE HYDROCHLORIDE | AvPAK | a9df4617-b406-70ba-e053-2995a90a28e8 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 078983 ANDA078983 50268-059 |
| Atomoxetine Hydrochloride | ATOMOXETINE HYDROCHLORIDE | REMEDYREPACK INC. | 6d7ea8f7-981c-4acc-aeaf-7516325bfc0c | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 078983 ANDA078983 |
| Atomoxetine Hydrochloride | ATOMOXETINE HYDROCHLORIDE | Golden State Medical Supply, Inc. | 6f14ced9-c16c-905a-e053-2a91aa0a031e | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 078983 ANDA078983 |
| Atomoxetine Hydrochloride | ATOMOXETINE HYDROCHLORIDE | Apotex Corp. | 132852a6-5bff-15dd-255c-98309dd83630 | 2025-04-02 | Boxed warning, Warnings, Adverse reactions | 078983 ANDA078983 |
| Atomoxetine Hydrochloride | ATOMOXETINE HYDROCHLORIDE | A-S Medication Solutions | 19b10860-aa08-4480-816c-c207819e5f9e | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 078983 ANDA078983 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atomoxetine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATOMOXETINE HYDROCHLORIDE | 60 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57WVB6I2W0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 349595 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a9df4617-b406-70ba-e053-2995a90a28e8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0d16f546-db6a-1939-50fc-d06382424c97 | Product name | 4 | 20210903 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50268-059-11 | Atomoxetine Hydrochloride | 1 in 1 BLISTER PACK | CAPSULE | 1 | 2 | |
| 50268-059-13 | Atomoxetine Hydrochloride | 30 in 1 BOX | CAPSULE | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-059-11 | EA - Each | 50268-059 | 70c65c2c-c5d9-4ed1-90f7-11ef00cec299 | 1 | 2020-08-06 |
| 50268-059-13 | EA - Each | 50268-059 | 354c0c74-bb98-4916-a29a-e8a388325f63 | 1 | 2020-08-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349595 | atomoxetine HCl 60 MG Oral Capsule | PSN | a9df4617-b406-70ba-e053-2995a90a28e8 | 2 |
| 349595 | atomoxetine 60 MG Oral Capsule | SCD | a9df4617-b406-70ba-e053-2995a90a28e8 | 2 |
| 349595 | atomoxetine 60 MG (as atomoxetine hydrochloride) Oral Capsule | SY | a9df4617-b406-70ba-e053-2995a90a28e8 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50268-059-11 | 50268005911 | 1 in 1 BLISTER PACK | Historical | |||||
| 50268-059-13 | 50268005913 | 30 BLISTER PACK in 1 BOX (50268-059-13) / 1 CAPSULE in 1 BLISTER PACK (50268-059-11) | 30 blister pack | 2020-07-07 | 0000-00-00 | No | No | Current |